Monotherapy for Rheumatoid Arthritis: Leveraging the Latest Evidence to Treat to Target

In this video module with accompanying downloadable slides and expert-authored ClinicalThought commentaries, learn best practices in the use of traditional, biologic, and targeted synthetic DMARD monotherapy to treat rheumatoid arthritis and discover new strategies for the multidisciplinary engagement of patients with this condition.
Jonathan Scott Coblyn, MD
Program Director
Jessica Farrell, PharmD
Frances Griffin, RN, BSN

Video Module

In this interactive, CME/CE/CPE-certified video module, Jonathan Scott Coblyn, MD; Jessica Farrell, PharmD; and Frances Griffin, RN, BSN, provide multidisciplinary perspectives on best practices in the use of traditional, biologic, and targeted synthetic DMARD monotherapy to treat rheumatoid arthritis.

Jonathan Scott Coblyn, MD
Program Director
Jessica Farrell, PharmD Frances Griffin, RN, BSN
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 29, 2018 Expired: No longer available for credit
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an educational grant from
Pfizer

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue